10.1016/j.jmb.2012.11.013 J
However, Mounjaro targets both GLP-1 and GIP receptors, making it a dual-action medication that may offer greater appetite suppression and improved metabolism for some patients
Support from The Care Pharmacy (UK) Managing weight-loss treatment can feel overwhelming, especially as new medicines like orforglipron move closer to approval
In clinical trials, 6-16% of participants discontinued retatrutide due to gastrointestinal adverse events (Jastreboff et al., NEJM, 2023)
Additionally, the company may find a market among patients who cannot take the full dose of semaglutide, building upon the trend of microdosing the medications
Currently, no official link exists between Ozempic and increased photosensitivity, though individuals with diabetes should maintain good sun safety practices as part of overall health management